| Name | N-[9-[(2R,3R,5S)-5-[[(2,3-dimethoxyphenyl)-diphenylmethoxy]methyl]-3-hydroxyoxolan-2-yl]purin-6-yl]benzamide |
|---|---|
| Synonyms |
N-(9-((2R,3R,5S)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-hydroxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide
N-Benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-3'-deoxyadenosine N6-Benzoyl-5'-O-(dimethoxytrityl)-3'-deoxyadenosine N6-Benzoyl-5’-O-(4,4-dimethoxytrityl)-3’-deoxy adenosine N6-Benzoyl-3'-deoxy-5'-O-DMT-adenosine Adenosine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-3'-deoxy N6-Benzoyl-5'-O-(4,4-dimethoxytrityl)-3'-deoxy adenosine |
| Description | N-Benzoyl-5′-O-[bis(4-methoxyphenyl)phenylmethyl]-3′-deoxyadenosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C38H35N5O6 |
|---|---|
| Molecular Weight | 657.71 |
| Exact Mass | 657.25900 |
| PSA | 129.85000 |
| LogP | 5.82590 |
| Precursor 7 | |
|---|---|
| DownStream 1 | |